第 1 頁 共 2 頁 v 1.1.1 發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 Philip Witherington, Nicole Arnaboldi, Guy Bainbridge, Julie Dickson, Michael Durland, Donald P. Kanak, Donald Lindsay, May Tan, Leagh Turner, Anna Manning, John Wong, Nancy Carroll and John Montalbano EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | | | | --- | --- | --- | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | | | | 股票發行人現金股息公告 | | | | | | 發行人名稱 | 宏利金融有限公司 | | | | | 股份代號 ...

Core Viewpoint - Manulife Financial Corporation (MFC) is experiencing strong investor confidence, reflected in its share price performance and growth potential, with a 12.1% increase over the past year compared to the industry's 4.9% growth [1][2]. Financial Performance - MFC shares closed at $30.75, near a 52-week high of $33.07, indicating positive market sentiment [1][7]. - The company has a market capitalization of $52.23 billion, with an average trading volume of 2.2 million shares over the last three months [3]. - MFC has a price-to-earnings ratio of 9.7X, which is above the industry average of 7.5X, indicating a premium valuation [4]. - The Zacks average price target for MFC is $35 per share, suggesting a potential upside of 13.82% from the last closing price [5]. Growth Projections - Analyst estimates for MFC's 2025 earnings per share indicate a year-over-year increase of 6%, with 2026 estimates showing an 8.9% increase in earnings and an 8.1% increase in revenues [9][10]. - The return on equity for MFC in the trailing 12 months was 15.7%, surpassing the industry average of 15.2%, highlighting the company's efficiency [13]. Strategic Focus - MFC aims for its Asia business to contribute to half of its core earnings by 2025, focusing on growth in this region [14]. - The company is expanding its Wealth and Asset Management business, particularly in Europe and the EMEA market, as a significant growth area [15]. - MFC is targeting a leverage ratio of 25% and has maintained a free cash flow conversion of over 100% in recent quarters, reflecting strong earnings [17]. Shareholder Returns - MFC has increased its dividend at a seven-year compound annual growth rate (CAGR) of 10% and targets a dividend payout ratio of 35-45% over the medium term [16]. - The company is committed to wealth distribution through higher dividends and share buybacks, making it attractive for yield-seeking investors [19].

EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | | | | --- | --- | --- | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | | | | 股票發行人現金股息公告 | | | | | | 發行人名稱 | 宏利金融有限公司 | | | | | 股份代號 | 00945 | | | | | 多櫃檯股份代號及貨幣 | 不適用 | | | | | 相關股份代號及名稱 | 不適用 | | | | | 公告標題 | 宏利宣布派發普通股股息 | | | | | 公告日期 | 2025年8月6日 | | | | | 公告狀態 | 更新公告 | | | | | 更新/撤回理由 | 更新匯率 | | | | | 股息信息 | | | | | | 股息類型 | 第二季度 | | | | | 股息性質 | 普通股息 | | | | | 財政年末 | 2025年12月31日 | | | | | 宣派股息的報告期末 | 2025年6月3 ...

Core Insights - Manulife Canada has launched a dedicated platform for travel agents to enhance the delivery of insurance solutions, adapting to the evolving needs of professionals and their clients [1][9] - The platform addresses the increasing importance of insurance among travelers, providing user-friendly tools for agents to engage with clients effectively [2] Product Offerings - The upgraded platform includes the Non-Medical Premium Protection Plan, which offers comprehensive trip protection without additional medical benefits for those already covered [3] - A streamlined Product Selector tool allows agents and clients to easily identify suitable travel insurance options, ensuring alignment with individual travel needs [4] Engagement and Efficiency - New engagement features enable agents to send automated reminders to clients, ensuring timely protection [4] - Built-in tracking tools provide measurable insights into engagement and productivity, while the scalable digital system enhances efficiency and cost management [6] Financial Implications - The platform is expected to strengthen Manulife Financial Corporation's financial position by increasing premium inflows from travel insurance sales, expanding the customer base, and improving client retention [5] - Enhanced client engagement and satisfaction are anticipated to boost the lifetime value of each customer [5] Market Performance - Year-to-date, Manulife's shares have decreased by 1.3%, slightly underperforming the broader industry decline of 1.2%, influenced by foreign exchange volatility and weaker premium growth in Canada [7]

Group 1 - Manulife's President and CEO, Phil Witherington, will participate in a fireside chat at the 26th Scotiabank Financials Summit on September 4, 2025, at 1:00 p.m. ET [1] - The live webcast and a replay of the fireside chat will be available on Manulife's Investor Relations website for 90 days following the live session [1] Group 2 - Manulife Financial Corporation is a leading international financial services provider with global headquarters in Toronto, Canada, operating as Manulife in Canada, Asia, and Europe, and as John Hancock in the United States [2] - The company offers financial advice and insurance for individuals, groups, and businesses, and provides global investment, financial advice, and retirement plan services through Manulife Wealth & Asset Management [2] - As of the end of 2024, Manulife had over 37,000 employees, more than 109,000 agents, and thousands of distribution partners, serving over 36 million customers [2] - Manulife trades as 'MFC' on the Toronto, New York, and Philippine stock exchanges, and under '945' in Hong Kong [2]

Core Insights - Manulife Canada and Centum Financial Group Inc. have renewed their partnership to enhance mortgage and financial protection solutions for Canadians [1][9] - The collaboration combines Centum's mortgage expertise with Manulife's wealth management experience, offering comprehensive financial solutions [2] Partnership Details - Centum Financial's agents will continue to provide Manulife's Mortgage Protection Plan, which includes life and disability insurance [3] - A new Group RRSP program will be available to Centum agents starting September 1, allowing them to pursue their financial goals while assisting clients [4] Business Impact - The partnership is expected to increase access to mortgage professionals, driving premium growth and enhancing cross-selling opportunities [5] - Mortgage-linked products are anticipated to generate predictable cash flows, improving operational efficiency and supporting long-term revenue growth [5] Market Performance - Year-to-date, Manulife's shares have decreased by 2.1%, compared to a 1.2% decline in the broader industry, indicating ongoing challenges [6]

Core Viewpoint - Manulife Financial-S reported a core profit of CAD 1.7 billion in Q2 2025, demonstrating progress in AI technology application and digital transformation despite operational pressures [1] AI Technology Driving Business Innovation - Manulife Financial-S achieved an industry-leading position in AI application, ranking first in the life insurance sector according to the inaugural EvidentAI Insurance Index [3] - The company launched an AI-driven sales support solution in the U.S. retirement market, resulting in a doubling of sales opportunities and a reduction of over 50% in information search time compared to Q2 2024 [3] - In Asia, the company introduced the VOICE analytics platform in Singapore and Japan, utilizing generative AI to analyze customer interactions and improve service quality [3] Financial Performance Under Pressure but Stable - For H1 2025, Manulife Financial-S reported total revenue of CAD 13.522 billion, slightly down from half of the CAD 25.823 billion reported for the full year of 2024 [4] - Shareholder profit was CAD 2.114 billion, with earnings per share at CAD 1.23, down from CAD 2.85 in 2024 [4] - The company maintained a high debt-to-equity ratio of 90.52%, similar to 90.24% in 2024, indicating potential impacts on financial flexibility [4] - Return on equity decreased to 4.23% from 10.35% in 2024, while total asset return fell from 0.98% to 0.39% [4] - Cash and cash equivalents were CAD 23.773 billion, down from CAD 25.789 billion at the end of 2024, but liquidity remains sufficient [4] Ongoing Global Business Expansion - Manulife Financial-S is enhancing distribution capabilities and expanding its product lineup to meet evolving customer needs [5] - The company saw a 23% year-on-year increase in MDRT membership in Asia, ranking third globally in 2025 [5] - It became the first international life insurance company to establish an office in the Dubai International Financial Centre, focusing on high-net-worth clients [5] - Product innovations include a diversified real asset strategy in Malaysia and a series of actively managed ETF products in Canada [5] - In the U.S., the long-term care business integrated GenAI features to automate claims processes, while a digital travel insurance platform was launched in Canada to enhance service experiences [5]

Core Viewpoint - Manulife Financial Corporation is identified as a strong long-term income investment in the insurance industry due to its solid business fundamentals and promising growth prospects [1]. Company Analysis - Manulife Financial Corporation operates within the insurance sector, showcasing robust business fundamentals that support its investment appeal [1]. - The company is expected to benefit from favorable growth prospects, which are critical for long-term income generation [1]. Industry Context - The insurance industry is characterized by companies with strong fundamentals, and Manulife is positioned well within this context [1].

Major Events - Silver诺医药-B (02591) is set to conduct an IPO from August 7 to August 12, with an expected listing date of August 15 [1] - Boan Biotech (06955) plans to place 48 million shares at a discount of approximately 8.78%, aiming to raise about HKD 780 million [1] - Derin Holdings (01709) intends to raise HKD 653.3 million, focusing on the development of blockchain, RWA, and virtual asset businesses [1] - Fuhong Hanlin (02696) received FDA approval to initiate a Phase 1 clinical trial for HLX43, a PD-L1 targeted antibody-drug conjugate for thymic cancer treatment [1] - China Biopharmaceutical (01177) obtained NMPA approval for the Phase II clinical trial application of LM-24C5, a dual antibody targeting CEACAM5/4-1BB [1] Financial Reports - China Mobile (00941) reported a shareholder profit of HKD 84.235 billion, a year-on-year increase of 5.03% [1] - Manulife Financial-S (00945) announced a core profit of CAD 1.7 billion for the second quarter [1] - Swire Properties (01972) reported a basic profit attributable to shareholders of HKD 4.42 billion, a year-on-year growth of 15% [1] - Hutchison Whampoa (00013) posted a net profit of USD 455 million, a significant year-on-year increase of 1663.32% [1] - MGM China (02282) disclosed a net profit of HKD 2.383 billion, a year-on-year decrease of 11.25% [1] - SMIC (00981) reported a shareholder profit of USD 132 million for the second quarter, with a revenue guidance for the third quarter indicating a sequential growth of 5% to 7% [1] - Zai Lab (09688) achieved a total revenue of approximately USD 216 million for the first half of the year, reflecting a year-on-year growth of 15.35% [1] - Innovent Biologics (01801) reported total product revenue exceeding RMB 5.2 billion for the first half of the year, maintaining a strong growth rate of over 35% [1] - Pacific Basin Shipping (02343) announced a profit attributable to shareholders of USD 25.6 million, a year-on-year decrease of 56% [1] - Lee & Man Paper Manufacturing (02314) reported a net profit of HKD 811 million, a year-on-year increase of 0.7%, with an interim dividend of HKD 0.066 per share [1] - Swire Group reported a profit attributable to shareholders of HKD 815 million for the first half of the year, a year-on-year decrease of 79% [1] - Lee & Man Chemical Company (00746) reported a profit increase of 36.0% to HKD 327 million, with an interim dividend of HKD 0.195 per share [1] - Hua Hong Semiconductor (01347) reported a profit attributable to parent company owners of USD 7.952 million for the second quarter, a year-on-year increase of 19.2% [1] - Wharf Real Estate Investment (01997) reported a loss attributable to shareholders of HKD 2.406 billion, a year-on-year increase of 128.71%, with the first interim dividend of HKD 0.066 per share [1] - Dekang Agriculture (02419) issued a profit warning, expecting a year-on-year increase in fair value adjustments of biological assets to approximately RMB 1.1 billion to 1.4 billion [1] - Mongol Mining (00975) issued a profit warning, anticipating a net loss of approximately USD 15 million to 25 million for the first half of the year, marking a shift from profit to loss [1] - Dongfeng Motor Group (00489) issued a profit warning, expecting a decline in net profit attributable to the parent company of 90% to 95% for the first half of the year [1]

Financial Data and Key Metrics Changes - The company's core EPS grew by 2% year-over-year, reflecting strong underlying business growth, although dampened by elevated U.S. mortality and expected credit loss provisions [12][13] - The balance sheet remains strong with a LICAT ratio of 136% and a leverage ratio well below the 25% target, while book value per share increased by 5% from the prior year [13][28] - Net income for the quarter was reported at $1.8 billion, an increase of $747 million compared to the prior year, driven by positive market experience [20] Business Line Data and Key Metrics Changes - The insurance segments generated over 30% growth in new business CSM, with AP sales increasing by 15% year-over-year, particularly strong in Asia and the U.S. [15][16] - Global Wealth and Asset Management (WAM) achieved nearly $1 billion in positive net flows, demonstrating the strength of its diversified platform [16][22] - Core earnings in Asia increased by 13% year-over-year, while the U.S. segment saw a 53% decrease in core earnings due to unfavorable mortality experience [21][26] Market Data and Key Metrics Changes - The Asia segment reported a 31% increase in APE, with significant contributions from Hong Kong, Mainland China, and Singapore [21] - In Canada, APE sales decreased by 34% year-over-year, primarily due to the non-recurrence of a large case sale in the Group Insurance business [24] - The U.S. segment experienced a 40% growth in AP sales, driven by demand for accumulation insurance products from affluent customers [26] Company Strategy and Development Direction - The company is focused on enhancing its digital capabilities and embedding AI across its businesses to drive growth and productivity [8][9] - The acquisition of Comvest Credit Partners is aimed at scaling the private markets business and enhancing existing private credit capabilities, expected to be immediately accretive to core EPS and ROE [10][31] - The leadership team is reviewing the company's strategy to assess potential refreshes to meet long-term ambitions [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver sustainable growth despite short-term headwinds impacting core earnings [29] - The company remains committed to investing in high-quality growth opportunities and maintaining strong capital deployment priorities [9][10] - Management acknowledged the challenges posed by elevated mortality claims in the U.S. but views them as short-term headwinds rather than a trend [26][27] Other Important Information - The company has returned over $6.4 billion in capital to shareholders through dividends and share buybacks over the past year [28] - The transition to the new eMPF platform in Hong Kong is expected to impact core earnings, with a projected quarterly drag of approximately $25 million starting in 2026 [24][84] Q&A Session Summary Question: What other areas may the company want to bulk up in operations? - The company is focused on organic growth opportunities but is also looking for inorganic opportunities that could accelerate growth, particularly in private markets and alternatives [40][41] Question: What is the expected impact of the MPS on margins? - The transition to eMPF is expected to impact margins by approximately 150 basis points, with a recovery anticipated thereafter [46][47] Question: Can you provide details on the amortization of intangibles from the Comvest acquisition? - The acquisition is expected to add approximately $30 million annually in amortization of intangibles, which will be excluded from core earnings [49][50] Question: How does the company justify the valuation paid for Comvest? - The valuation reflects the future value expected from the acquisition, with significant growth opportunities in private credit and alignment of interests between the two firms [70][72] Question: What is the outlook for the Japan market? - The company sees continued growth potential in Japan, despite a decline in sales due to strong prior year performance, and is diversifying its product offerings [80][81]